Choosing antithrombotics for atrial fibrillation in primary care
Atrial fibrillation (AF) is the most common cardiac arrhythmia in the UK affecting 1.3 million people. AF is particularly common in older people, with one in ten over the age of 75 years affected. The prevalence of AF is projected to increase with improved survival of patients from chronic cardiac d...
Автори: | Mustafa, M, Sheppard, JP |
---|---|
Формат: | Journal article |
Мова: | English |
Опубліковано: |
Royal College of General Practictioners
2020
|
Схожі ресурси
Схожі ресурси
-
Antithrombotic therapy for atrial fibrillation and comorbidities — how to choose the optimal solution?
за авторством: E V Schlyakhto, та інші
Опубліковано: (2022-01-01) -
Dual antithrombotic therapy and gastroprotection in atrial fibrillation: an observational primary care study
за авторством: Charis Xuan Xie, та інші
Опубліковано: (2022-12-01) -
ANTITHROMBOTIC THERAPY IN NONVALVULAR ATRIAL FIBRILLATION: PROBLEMS AND PROSPECTS
за авторством: A. Y. Rychkov, та інші
Опубліковано: (2016-01-01) -
Comparative Analysis of Antithrombotic Therapy in In-Patients with Atrial Fibrillation
за авторством: V. I. Petrov, та інші
Опубліковано: (2019-03-01) -
APPROACHES TO ANTITHROMBOTIC THERAPY IN ELDERLY PATIENTS WITH ATRIAL FIBRILLATION
за авторством: E. A. Ushkalova, та інші
Опубліковано: (2017-05-01)